Profile data is unavailable for this security.
About the company
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
- Revenue in USD (TTM)4.80m
- Net income in USD-60.61m
- Incorporated2003
- Employees79.00
- LocationBioLine RX LtdModi'in Technology Park2 HaMa'ayan StreetMODIIN 7177871IsraelISR
- Phone+972 86429100
- Fax+972 86429101
- Websitehttps://www.biolinerx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equillium Inc | 37.89m | -12.13m | 49.36m | 44.00 | -- | 2.34 | -- | 1.30 | -0.3476 | -0.3476 | 1.08 | 0.5983 | 0.6568 | -- | 8.95 | 861,227.30 | -21.02 | -46.81 | -39.66 | -57.36 | -- | -- | -32.01 | -328.35 | -- | -- | 0.00 | -- | 128.97 | -- | 78.64 | -- | 7.48 | -- |
| Dyadic International Inc | 2.26m | -7.85m | 49.70m | 7.00 | -- | 10.99 | -- | 22.04 | -0.2724 | -0.2724 | 0.0783 | 0.1547 | 0.1769 | -- | 4.51 | 322,197.20 | -61.58 | -36.82 | -73.50 | -39.85 | 38.24 | 22.47 | -348.00 | -410.16 | -- | -- | 0.5634 | -- | -1.07 | 17.48 | 30.20 | -- | -- | -- |
| Journey Medical Corp | 80.00m | -4.16m | 50.45m | 58.00 | -- | 5.54 | -- | 0.6306 | -0.3095 | -0.3095 | 4.13 | 0.6498 | 0.985 | 2.27 | 4.28 | 1,379,276.00 | -5.12 | -- | -17.85 | -- | 66.22 | -- | -5.20 | -- | 0.9357 | 0.4049 | 0.5773 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
| Ocean Biomedical Holdings Inc | 0.00 | -45.58m | 50.93m | 9.00 | -- | -- | -- | -- | -1.40 | -1.40 | 0.00 | -0.0642 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -612.50 | -- | -- | -- |
| Inotiv Inc | 552.74m | -71.29m | 51.42m | 1.96k | -- | 0.2476 | -- | 0.093 | -2.77 | -2.77 | 21.44 | 8.00 | 0.6565 | 7.18 | 7.91 | 282,733.50 | -8.58 | -23.84 | -13.63 | -29.26 | 28.76 | 29.31 | -13.07 | -33.24 | 0.2744 | -0.1734 | 0.6476 | -- | 4.52 | 85.10 | 68.80 | -- | 83.64 | -- |
| Moolec Science SA | 2.65m | -52.66m | 51.80m | 45.00 | -- | 5.11 | -- | 19.58 | -1.44 | -1.44 | 0.0766 | 0.2367 | -- | -- | -- | 58,780.00 | -- | -- | -- | -- | 2.92 | -- | -1,990.79 | -- | 0.2243 | -0.1889 | 0.2372 | -- | -- | -- | -1,044.02 | -- | -- | -- |
| Carmell Corp | 0.00 | -18.29m | 52.22m | 9.00 | -- | -- | -- | -- | -1.58 | -1.49 | 0.00 | -0.0719 | 0.00 | -- | -- | 0.00 | -428.46 | -- | -- | -- | 58.60 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -75.70 | -- | -- | -- |
| Carisma Therapeutics Inc | 15.07m | -81.22m | 52.34m | 107.00 | -- | 4.80 | -- | 3.47 | -2.01 | -2.01 | 0.3723 | 0.2623 | 0.1311 | -- | -- | 140,869.20 | -70.64 | -30.87 | -83.17 | -34.47 | -- | -- | -538.81 | -255.66 | -- | -- | 0.1717 | -- | -62.70 | -- | -336.93 | -- | 255.27 | -- |
| BioLine RX Ltd - ADR | 4.80m | -60.61m | 52.62m | 79.00 | -- | 3.31 | -- | 10.96 | -0.9509 | -0.9509 | 0.0747 | 0.1825 | 0.0684 | -- | 5.03 | 60,759.49 | -86.40 | -52.74 | -122.73 | -65.43 | 23.08 | -- | -1,262.79 | -3,501.79 | 1.47 | -425.65 | 0.4671 | -- | -- | -- | -142.93 | -- | -50.72 | -- |
| Kezar Life Sciences Inc | 7.00m | -101.87m | 53.04m | 58.00 | -- | 0.2827 | -- | 7.58 | -1.40 | -1.40 | 0.0965 | 2.58 | 0.0269 | -- | -- | 120,689.70 | -39.12 | -32.54 | -41.41 | -34.09 | -- | -- | -1,455.29 | -4,308.11 | -- | -- | 0.051 | -- | -- | -- | -49.28 | -- | 10.08 | -- |
| Enzo Biochem Inc | 32.80m | -23.31m | 53.79m | 179.00 | -- | 0.749 | -- | 1.64 | -0.4699 | 0.6708 | 0.6586 | 1.40 | 0.3738 | 1.61 | 4.10 | 183,257.00 | -26.56 | -12.21 | -39.50 | -15.79 | 42.17 | 37.09 | -71.07 | -18.76 | 2.89 | -- | 0.0476 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
| Cidara Therapeutics Inc | 46.38m | -36.47m | 54.38m | 69.00 | -- | -- | -- | 1.17 | -8.07 | -8.07 | 10.26 | -3.90 | 0.6899 | -- | 2.80 | 672,144.90 | -54.24 | -65.23 | -218.59 | -154.37 | 76.93 | -- | -78.63 | -100.61 | 0.6047 | -- | -- | -- | -0.8425 | -- | 31.72 | -- | 23.33 | -- |
| Rockwell Medical Inc | 86.62m | -8.42m | 55.02m | 237.00 | -- | -- | -- | 0.6352 | -0.3584 | -0.3584 | 3.33 | -- | -- | -- | -- | 365,485.20 | -- | -46.29 | -- | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | -- | -3.41 | -- | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
| Calcimedica Inc | 0.00 | -14.94m | 55.47m | 14.00 | -- | 3.21 | -- | -- | -2.64 | -2.64 | 0.00 | 1.61 | 0.00 | -- | -- | 0.00 | -48.34 | -63.99 | -66.59 | -72.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.51 | -- | -44.35 | -- |
| China Health Industries Holdings, Inc. | 117.28k | -1.51m | 55.71m | 32.00 | -- | -- | -- | 475.01 | -0.023 | -0.023 | 0.0018 | -0.0349 | 0.0044 | 0.5692 | 25.25 | 3,665.00 | -5.72 | 3.04 | -7.60 | 3.66 | -2.37 | 69.55 | -1,287.13 | 28.61 | 0.0377 | -- | 1.68 | -- | 41,225.93 | -55.72 | -15.49 | -- | -- | -- |
Data as of May 24 2024. Currency figures normalised to BioLine RX Ltd's reporting currency: US Dollar USD
